Evidence map›Paper›PMID 32635149›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Ameliorative Effects of Rhoifolin in Scopolamine-Induced Amnesic Zebrafish (

Ion Brinza, Ahmed M Abd-Alkhalek, Mohamed A El-Raey, Razvan Stefan Boiangiu, Omayma A Eldahshan, Lucian Hritcu

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Effect of aPharmaceuticals (Basel, Switzerland) · 2024
    Article
  8. Direct Evidence for UsingAntioxidants (Basel, Switzerland) · 2023
    Article
  9. In Vitro Antiviral Effect and Potential Neuroprotection ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  10. Promnesic, Anxiolytic and Antioxidant Effects ofPlants (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Review
  13. Neuroprotective Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Neuroprotective Potential ofPlants (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Wound-Healing Potential of Rhoifolin-Rich Fraction Isolated fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  18. In Vitro and In Vivo Studies of Anti-Lung Cancer Activity ofAntioxidants (Basel, Switzerland) · 2021
    Article
  19. Molecules (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ion BrinzaDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.
Ahmed M Abd-AlkhalekFaculty of Medicine, Al-Azhar University, Cairo 11651, Egypt.
Mohamed A El-RaeyDepartment of Phytochemistry and Plant Systematics, Pharmaceutical Division, National Research Centre, Dokki, Cairo 12622, Egypt.
Razvan Stefan BoiangiuDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.ORCID 0000-0002-2602-4882
Omayma A EldahshanDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0002-0972-0560
Lucian HritcuDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.ORCID 0000-0001-6981-4174
Alexandru Ioan Cuza University · ROAin Shams University · EGAl-Azhar University · EGNational Research Centre · EG

Funding

This project is funded by the Ministry of Research and Innovation within Program 1 - Development of the national RD system, Subprogram 1.2 - Institutional Performance - RDI excellence funding projects Contract no. 34PFE/19.10.2018
6 · The paper itself

Abstract

Rhoifolin (Rho) exerts many biological activities such as anticancer, antidiabetic, hepatoprotective, antirheumatic, antibacterial, and antiviral properties. The neuroprotective action of this compound has not been studied. The goal of this study was to investigate the improvement impact of Rho on scopolamine (Sco)-induced zebrafish anxiety, amnesia, and brain oxidative stress and to elucidate the underlying mechanisms involved. Zebrafish were treated with Rho (1, 3, and 5 μg/L) for nine consecutive days and were subsequently subjected to Sco (100 μM) 30 min before behavioral tests (novel tank diving test, Y-maze, and novel object recognition tests). Rho was isolated from

Indexed as

anxietycholinergic functionmemoryoxidative stressrhoifolinzebrafish

Identifiers

PMID32635149
PMCPMC7401873
OpenAlexW3038852650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.